Entero Healthcare Solutions Limited (NSE:ENTERO)
India · Delayed Price · Currency is INR 996.40
-10.30 (-1.02%)
At close: Dec 12, 2025
NSE:ENTERO Revenue
Entero Healthcare Solutions had revenue of 15.71B INR in the quarter ending September 30, 2025, with 20.78% growth. This brings the company's revenue in the last twelve months to 56.73B, up 28.21% year-over-year. In the fiscal year ending March 31, 2025, Entero Healthcare Solutions had annual revenue of 50.96B with 29.92% growth.
Revenue (ttm)
56.73B
Revenue Growth
+28.21%
P/S Ratio
0.77
Revenue / Employee
13.80M
Employees
4,111
Market Cap
43.80B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 50.96B | 11.73B | 29.92% |
| Mar 31, 2024 | 39.22B | 6.22B | 18.85% |
| Mar 31, 2023 | 33.00B | 7.78B | 30.85% |
| Mar 31, 2022 | 25.22B | 7.49B | 42.24% |
| Mar 31, 2021 | 17.73B | 4.23B | 31.38% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 549.64B |
| Aurobindo Pharma | 325.14B |
| Cipla | 279.66B |
| Zydus Lifesciences | 244.94B |
| Apollo Hospitals Enterprise | 232.65B |
| Glenmark Pharmaceuticals | 159.97B |
| Alkem Laboratories | 138.90B |
| Mankind Pharma | 135.46B |
Entero Healthcare Solutions News
- 4 weeks ago - Entero Healthcare Solutions Ltd (NSE:ENTERO) Q2 2026 Earnings Call Highlights: Strong Revenue ... - GuruFocus
- 4 weeks ago - Q2 2026 Entero Healthcare Solutions Ltd Earnings Call Transcript - GuruFocus